IN8bio, Inc.

IN8bio, Inc.:
IN8bio focuses on developing allogeneic, autologous and genetically modified gamma-delta T cells therapies for cancer treatments using its DeltEx Platform, based on ex-vivo expanded and activated gamma-delta T cells. First company to advance modified gamma-delta T cells into clinical trials. IN8bio has completed first cohort dosing for its two investigator-initiated Phase 1 clinical trials INB-200 for the treatment of newly diagnosed glioblastoma, which is a difficult to treat brain tumor that progresses rapidly, and INB-100 for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Phase l or ll
Disease Space
Oncology
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy, Gene Therapy
Website:
Address:
79 Madison Ave.
New York, NY 10016
United States
New York, NY 10016
United States
More info:
My account:
Company Participants at Solebury Trout 1x1 Management Access Event 2022
- Charles Butler, Vice President, Corporate Communications & Investor Relations
- William T. Ho, President/CEO/Co-Founder
Top 10 Holders of IN8bio, Inc.
Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
---|---|---|---|---|---|
Voss Capital LLC | 1.38 | 338,019 | 0.41 | 13F | 12/31/22 |
Stonegate Investment Group LLC | 0.95 | 232,310 | 0.28 | 13F | 12/31/22 |
The Vanguard Group, Inc. | 0.84 | 204,860 | 0.25 | Funds | 2/28/23 |
Vanguard Group, Inc. (Subfiler) | 0.69 | 168,656 | 0.20 | 13F | 12/31/22 |
Sigma Planning Corp. | 0.40 | 99,150 | 0.12 | 13F | 12/31/22 |
The Rock Creek Group LP | 0.33 | 81,568 | 0.10 | 13F | 12/31/22 |
Bridgeway Capital Management LLC | 0.30 | 74,000 | 0.09 | 13F | 12/31/22 |
Ensign Peak Advisors, Inc. | 0.29 | 70,028 | 0.08 | 13F | 12/31/22 |
Geode Capital Management LLC | 0.24 | 58,665 | 0.07 | 13F | 12/31/22 |
BlackRock Fund Advisors | 0.12 | 29,568 | 0.04 | 13F | 12/31/22 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.